Racial and ethnic disparities in neoadjuvant chemotherapy patterns and outcomes in early-stage HER2-positive breast cancer

Abstract We examined neoadjuvant chemotherapy (NACT) use, pathological complete response (pCR) and the association with overall survival (OS) among patients with early-stage HER2-positive breast cancer (BC). Patients ≥18 years with stage I-III HER2-positive BC from 2010–2022 who had surgery and chem...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Inimfon Jackson, Xiudong Lei, Hui Zhao, Rashmi Murthy, Sharon H. Giordano, Mariana Chavez-MacGregor
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Nature Portfolio 2025-12-01
Edice:	npj Breast Cancer
On-line přístup:	https://doi.org/10.1038/s41523-025-00854-4
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!